Liraglutide (Victoza for diabetes, Saxenda for weight management), administered daily, has similar gastrointestinal side effect rates, with nausea reported in 1840% of patients, particularly during dose titration
People originally used it for sports injuries and post-surgery recovery
Novo Nordisk's R&D efforts, including AI partnerships, have yet to yield comparable breakthroughs, leaving it challenged to compete with Lilly's advanced pipeline
Metabolic peptide research has entered one of its most exciting phases in modern scientific history
They should only be used exactly as tested, approved, and prescribed
Extended BRAT eating can actually worsen nutritional status and delay gut adaptation